Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes
- R. A. Lafferty; P. R. Flatt; N. Irwin Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes Curr Opin Endocrinol Diabetes Obes
Publication Category: Obesity-related conditions
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation
-
A. M. Lynch; N. Pathak; V. Pathak; F. P. M. O’Harte; P. R. Flatt; N. Irwin; V. A. Gault
A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation Diabetologia
Complications of obesity
-
D. Kinlen; D. Cody; D. O'Shea
Complications of obesity Qjm
Adipokines and psoriasis: the obesity link
-
B. Kirby; M. Lynch
Adipokines and psoriasis: the obesity link Br J Dermatol
Obesity is associated with reduced cerebral blood flow – modified by physical activity
-
S. P. Knight; E. Laird; W. Williamson; J. O'Connor; L. Newman; D. Carey; C. De Looze; A. J. Fagan; M. A. Chappell; J. F. Meaney; R. A. Kenny
Obesity is associated with reduced cerebral blood flow – modified by physical activity Neurobiol Aging
Obesity and carotid artery remodeling
-
M. Kozakova; C. Palombo; C. Morizzo; K. Højlund; M. Hatunic; B. Balkau; P. M. Nilsson; E. Ferrannini
Obesity and carotid artery remodeling Nutr Diabetes
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity
-
H. Y. Kim; H. J. Lee; Y. J. Chang; M. Pichavant; S. A. Shore; K. A. Fitzgerald; Y. Iwakura; E. Israel; K. Bolger; J. Faul; R. H. DeKruyff; D. T. Umetsu
Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity Nat Med
Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level
-
K. Kearns; A. Dee; A. P. Fitzgerald; E. Doherty; I. J. Perry
Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level BMC Public Health
Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis
-
B. J. Kendall; J. H. Rubenstein; M. B. Cook; T. L. Vaughan; L. A. Anderson; L. J. Murray; N. J. Shaheen; D. A. Corley; A. K. Chandar; L. Li; K. B. Greer; A. Chak; H. B. El-Serag; D. C. Whiteman; A. P. Thrift
Inverse Association Between Gluteofemoral Obesity and Risk of Barrett’s Esophagus in a Pooled Analysis Clin Gastroenterol Hepatol
Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice
- N. Irwin; I. A. Montgomery; R. C. Moffett; P. R. Flatt Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice Biochem Pharmacol